Global X Genomics & Biotechnology ETF
GNOM
63 hedge funds and large institutions have $124M invested in Global X Genomics & Biotechnology ETF in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 5 closing their positions.
1.12% more ownership
Funds ownership: 16.41% → 17.53% (+1.1%)
6% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 18
0% more funds holding
Funds holding: 63 → 63 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
3% less capital invested
Capital invested by funds: $128M → $124M (-$3.82M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$23.2M |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$890K |
| 3 |
Jane Street
New York
|
+$536K |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$369K |
| 5 |
MWAM
Manhattan West Asset Management
Los Angeles,
California
|
+$330K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$4.54M |
| 2 |
PFG
Prosperity Financial Group
San Ramon,
California
|
-$1.91M |
| 3 |
Rockefeller Capital Management
New York
|
-$359K |
| 4 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
-$300K |
| 5 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
-$89K |
GNOM Hedge Fund Activity: Q3 2023 in Review
63 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q3 2023, worth a combined $124M — down 3% from $128M a quarter earlier.
Fund positioning in GNOM was balanced in Q3 2023: 5 funds opened new positions, 5 closed out, 19 added to existing stakes and 18 trimmed.
The largest buyer was Northwestern Mutual Wealth Management, adding an estimated $23.2M. The largest seller was Private Advisor Group, cutting an estimated $4.54M.
- 63 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $124M of Global X Genomics & Biotechnology ETF stock for Q3 2023, down 3% quarter-over-quarter.
- 5 funds opened new Global X Genomics & Biotechnology ETF positions in Q3 2023 and 5 closed out, a net change of 0 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q3 2023 was Northwestern Mutual Wealth Management, an estimated $23.2M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q3 2023 was Private Advisor Group, an estimated $4.54M sold.
Based on aggregated 13F filings for Q3 2023.